OrthoSpace completed financing which will facilitate growth in the future.
Here are five things to know:
1. The financing was led by HealthpointCapital.
2. The financing also included existing investors Smith & Nephew and TriVentures.
3. The proceeds will facilitate continued market adoption, clinical study programs and entry into the emerging markets.
4. OrthoSpace's flagship product is InSpace, a disruptive technology for treating severe rotator cuff tears. The technology addresses a large growing market segment with limited treatment options for the continuum-of-care for rotator cuff injury.
5. The terms of the agreement were not disclosed.
"With five years of clinical experience and over 5,000 procedures completed, we have developed a loyal following among surgeons in Europe and Israel," said Assaf Dekel, MD, OrthoSpace's co-founder and medical director.